Supply of Ophthalmic Antibiotic/Anti-inflammatory Medication (Ciprofloxacin/Dexamethasone)

The contract entails the manufacture or supply of FDA-approved sterile ophthalmic suspension containing ciprofloxacin hydrochloride and dexamethasone for delivery to a U.S. Navy vessel. The product must strictly adhere to current good manufacturing practices, Defense Logistics Agency specifications, and Defense Priority and Allocation System requirements to ensure quality, safety, and regulatory compliance. This is a subcontract under the Department of Defense, managed by the Defense Logistics Agency, and is intended to support military medical needs with a sterile ophthalmic medication that combines antibiotic and anti-inflammatory properties. The contract was posted on August 5, 2026, and is categorized under NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. Performance is tied to military operations, requiring precise adherence to federal procurement standards and delivery protocols for use onboard naval vessels.